What follow-up tests do I need after MDS treatment ends

Follow-Up Testing After MDS Treatment

I'm glad you're thinking ahead about monitoring after treatment. Follow-up testing is crucial for MDS because the disease can change over time, and your care team needs to track how your blood counts and bone marrow are doing.

Standard Follow-Up Tests

According to the NCCN Guidelines for Myelodysplastic Syndromes, your follow-up should include:

Regular Blood Work (CBC - Complete Blood Count)

• Frequency: Generally every 3-6 months, though this depends on your specific situation
• What it measures:
  • Red blood cell count (hemoglobin and hematocrit)
  • White blood cell count
  • Platelet count
  • Differential (types of white blood cells)
  • Reticulocyte count (young red blood cells, which shows how well your marrow is making new cells)

Peripheral Blood Smear

• Your doctor examines blood cells under a microscope to look for abnormal cell shapes or blast cells (immature cells)
• Usually done alongside your CBC

Bone Marrow Testing

The timing and frequency depend on your risk level and how you responded to treatment:

• Bone marrow aspiration (removing fluid from the marrow)
• Bone marrow biopsy (removing a small tissue sample)
• Cytogenetics (chromosome analysis to look for abnormalities)

These are typically repeated if:

• Your blood counts change significantly
• You develop new symptoms
• Your doctor suspects disease progression

Why These Tests Matter

The NCCN Guidelines emphasize that regular monitoring helps identify:

• Disease progression (worsening to higher-risk MDS or acute myeloid leukemia/AML)
• Treatment response (whether your previous treatment is still working)
• New mutations (genetic changes that might affect future treatment decisions)
• Cytopenias (low blood counts) that need supportive care

Important Factors That Affect Your Schedule

Your specific follow-up plan depends on:

• Your IPSS-R risk score (prognostic scoring system that predicts how your disease will behave)
• Whether you had lower-risk or higher-risk MDS
• Your response to treatment (complete response, partial response, or no response)
• Any cytogenetic abnormalities found in your marrow
• Your molecular mutations (specific gene changes identified in testing)

Questions to Ask Your Oncologist

Since your specific situation requires your doctor's evaluation, here are key questions to clarify your follow-up plan:

1. "Based on my risk level and treatment response, how often should I have blood work and bone marrow testing?"

2. "What specific changes in my blood counts or symptoms should prompt me to call you between scheduled visits?"

3. "Will you repeat molecular testing (gene mutation analysis) during follow-up, and if so, when?"

4. "What are the signs of disease progression I should watch for?"

5. "Do I need any other tests, like imaging studies or additional specialized blood work?"

Key Monitoring Principle

According to NCCN Guidelines, the clinical discretion of your oncologist is important—while these frequencies (every 3-6 months) are reasonable based on transformation risk, your doctor may adjust based on your individual case, your initial risk category, and how you've responded to treatment.

Your oncologist will determine the most appropriate follow-up schedule for YOUR specific case based on your complete clinical picture, including your initial diagnosis, treatment received, and current disease status.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.